B Olshansky

Summary

Affiliation: University of Iowa
Country: USA

Publications

  1. ncbi request reprint Anticoagulation: new challenges, old drugs
    Brian Olshansky
    Department of Internal Medicine, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, 4426A JCP, Iowa City, IA 52242, USA
    Curr Cardiol Rep 7:359-61. 2005
  2. doi request reprint Does cardiac resynchronization therapy provide unrecognized benefit in patients with prolonged PR intervals? The impact of restoring atrioventricular synchrony: an analysis from the COMPANION Trial
    Brian Olshansky
    University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA
    Heart Rhythm 9:34-9. 2012
  3. pmc Dronedarone: evidence supporting its therapeutic use in the treatment of atrial fibrillation
    Renee M Sullivan
    Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA
    Core Evid 5:49-59. 2010
  4. doi request reprint Increased prevalence of atrial fibrillation in the endurance athlete: potential mechanisms and sport specificity
    Brian Olshansky
    Professor Emeritus, University of Iowa Hospitals, Iowa City and Mercy Hospital, Mason City, IA
    Phys Sportsmed 42:45-51. 2014
  5. doi request reprint Sudden death risk in syncope: the role of the implantable cardioverter defibrillator
    Brian Olshansky
    University of Iowa Hospitals, Iowa City, IA 52242, USA
    Prog Cardiovasc Dis 55:443-53. 2013
  6. doi request reprint Inappropriate sinus tachycardia
    Brian Olshansky
    Department of Internal Medicine, Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242, USA
    J Am Coll Cardiol 61:793-801. 2013
  7. ncbi request reprint Use of amiodarone for atrial fibrillation in patients with preexisting pulmonary disease in the AFFIRM study
    Brian Olshansky
    University of Iowa, Iowa City, Iowa, USA
    Am J Cardiol 95:404-5. 2005
  8. ncbi request reprint Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study
    Brian Olshansky
    University of Iowa Hospitals, 200 Hawkins Drive, Iowa City, IA 52242, USA
    J Am Coll Cardiol 45:2026-33. 2005
  9. doi request reprint Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy
    Brian Olshansky
    Division of Cardiology, University of Iowa Hospitals, 200 Hawkins Dr 4426a JCP, Iowa City, IA 52242, USA
    Circulation 118:863-71. 2008
  10. doi request reprint Differential pharmacological effects of antimuscarinic drugs on heart rate: a randomized, placebo-controlled, double-blind, crossover study with tolterodine and darifenacin in healthy participants > or = 50 years
    Brian Olshansky
    University of Iowa Hospitals, Iowa City, Iowa 52242, USA
    J Cardiovasc Pharmacol Ther 13:241-51. 2008

Detail Information

Publications73

  1. ncbi request reprint Anticoagulation: new challenges, old drugs
    Brian Olshansky
    Department of Internal Medicine, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, 4426A JCP, Iowa City, IA 52242, USA
    Curr Cardiol Rep 7:359-61. 2005
    ....
  2. doi request reprint Does cardiac resynchronization therapy provide unrecognized benefit in patients with prolonged PR intervals? The impact of restoring atrioventricular synchrony: an analysis from the COMPANION Trial
    Brian Olshansky
    University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA
    Heart Rhythm 9:34-9. 2012
    ..The influence of PR prolongation on outcomes after cardiac resynchronization therapy (CRT) is uncertain...
  3. pmc Dronedarone: evidence supporting its therapeutic use in the treatment of atrial fibrillation
    Renee M Sullivan
    Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA
    Core Evid 5:49-59. 2010
    ..Dronedarone, a benzofuran derivative with a structure similar to amiodarone, has been developed as a potential therapy for patients with atrial fibrillation...
  4. doi request reprint Increased prevalence of atrial fibrillation in the endurance athlete: potential mechanisms and sport specificity
    Brian Olshansky
    Professor Emeritus, University of Iowa Hospitals, Iowa City and Mercy Hospital, Mason City, IA
    Phys Sportsmed 42:45-51. 2014
    ..Finally, we consider some of the options that are available to treat athletes who develop atrial fibrillation. ..
  5. doi request reprint Sudden death risk in syncope: the role of the implantable cardioverter defibrillator
    Brian Olshansky
    University of Iowa Hospitals, Iowa City, IA 52242, USA
    Prog Cardiovasc Dis 55:443-53. 2013
    ..This review focuses on the sudden death risk in patients with syncope and explores the role of the ICD to treat ventricular arrhythmias, prevent symptoms, and prevent death...
  6. doi request reprint Inappropriate sinus tachycardia
    Brian Olshansky
    Department of Internal Medicine, Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242, USA
    J Am Coll Cardiol 61:793-801. 2013
    ..Overtreatment, in an attempt to reduce symptoms, can be difficult to avoid, but is discouraged...
  7. ncbi request reprint Use of amiodarone for atrial fibrillation in patients with preexisting pulmonary disease in the AFFIRM study
    Brian Olshansky
    University of Iowa, Iowa City, Iowa, USA
    Am J Cardiol 95:404-5. 2005
    ..Cautious use of amiodarone to treat atrial fibrillation appears acceptable in elderly patients with atrial fibrillation, even if preexisting pulmonary disease is present...
  8. ncbi request reprint Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study
    Brian Olshansky
    University of Iowa Hospitals, 200 Hawkins Drive, Iowa City, IA 52242, USA
    J Am Coll Cardiol 45:2026-33. 2005
    ..The purpose of this study was to evaluate the associations of transthoracic echocardiographic parameters with recurrent atrial fibrillation (AF) and/or stroke...
  9. doi request reprint Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy
    Brian Olshansky
    Division of Cardiology, University of Iowa Hospitals, 200 Hawkins Dr 4426a JCP, Iowa City, IA 52242, USA
    Circulation 118:863-71. 2008
  10. doi request reprint Differential pharmacological effects of antimuscarinic drugs on heart rate: a randomized, placebo-controlled, double-blind, crossover study with tolterodine and darifenacin in healthy participants > or = 50 years
    Brian Olshansky
    University of Iowa Hospitals, Iowa City, Iowa 52242, USA
    J Cardiovasc Pharmacol Ther 13:241-51. 2008
    ..0114) but did not differ between darifenacin and placebo. The results show that antimuscarinics exert differential effects on heart rate depending on their muscarinic receptor profile. This should be considered when selecting a treatment...
  11. doi request reprint Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study
    Brian Olshansky
    University of Iowa, Iowa City, Iowa, USA
    J Am Coll Cardiol 51:1277-82. 2008
    ..The outcome of congestive heart failure (CHF) patients with syncope is understood incompletely...
  12. ncbi request reprint Eliminating right ventricular pacing may not be best for patients requiring implantable cardioverter-defibrillators
    Brian Olshansky
    University of Iowa Hospitals, Iowa City, IA 52242, USA
    Heart Rhythm 4:886-91. 2007
    ..It remains uncertain how much RV pacing is clinically deleterious...
  13. ncbi request reprint Acute anticoagulation adjustment in patients with atrial fibrillation at risk for stroke: approaches, strategies, risks and benefits
    Brian Olshansky
    Cardiac Electrophysiology, University of Iowa Hospitals, 4426A JCP, 200 Hawkins Drive, Iowa City, IA 52242, USA
    Expert Rev Cardiovasc Ther 3:571-90. 2005
    ..This analysis provides practical recommendations based on available data and presents results from recent investigations that may provide insight into future strategies...
  14. ncbi request reprint Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Brian Olshansky
    Department of Internal Medicine, University of Iowa Hospitals, 4426A JCP, 200 Hawkins Dr, Iowa City, IA 52242, USA
    Am Heart J 153:1089-94. 2007
    ..In the SCD-HeFT, mortality of patients with CHF was assessed after randomization to an implantable cardioverter/defibrillator (ICD), amiodarone, or placebo. The aim of this study was to evaluate the location of deaths in SCD-HeFT...
  15. ncbi request reprint Interrelationships between the autonomic nervous system and atrial fibrillation
    Brian Olshansky
    Department of Internal Medicine, University of Iowa Hospitals, Iowa City, IA 52242, USA
    Prog Cardiovasc Dis 48:57-78. 2005
    ..This article reviews what is known regarding the inter-relationships between the autonomic nervous system and atrial fibrillation and provides state of the art information at all levels of autonomic interactions...
  16. ncbi request reprint Placebo and nocebo in cardiovascular health: implications for healthcare, research, and the doctor-patient relationship
    Brian Olshansky
    Cardiac Electrophysiology, University of Iowa Hospitals, 4426A JCP, 200 Hawkins Drive, Iowa City, Iowa 52242, USA
    J Am Coll Cardiol 49:415-21. 2007
    ..Healthcare, rendered by a faceless, uncaring army of protocol aficionados, will miss an opportunity to deliver an effective placebo response. Wise placebo use can benefit patients and strengthen the medical profession...
  17. ncbi request reprint Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) study
    Brian Olshansky
    University of Iowa Hospitals, 200 Hawkins Dr, Iowa City, IA 52242, USA
    Circulation 115:9-16. 2007
    ....
  18. ncbi request reprint Fast-track training of nonelectrophysiologists to implant defibrillators: is it needed?
    Brian Olshansky
    University of Iowa School of Medicine, Iowa City, Iowa, USA
    Pacing Clin Electrophysiol 29:627-31. 2006
    ..We are particularly concerned about the disruption of training pathways in medicine and how this can affect patient care and can influence established training pathways in medicine...
  19. ncbi request reprint Inhibition of Unnecessary RV Pacing with AV Search Hysteresis in ICDs (INTRINSIC RV): design and clinical protocol
    Brian Olshansky
    University of Iowa Hospitals, Iowa City, Iowa 52242, USA
    Pacing Clin Electrophysiol 28:62-6. 2005
    ..Patients are followed for one year. This large, randomized, controlled, clinical trial will address whether DDDR with AVSH programming is equivalent to VVI programming in an ICD with regard to mortality and heart failure hospitalization...
  20. ncbi request reprint Location of death (in-hospital or out-of-hospital) and type of death (arrhythmic, nonarrhythmic, noncardiac) after inducible sustained ventricular tachyarrhythmias after syncope, sustained ventricular tachycardia, or nonfatal cardiac arrest (the ESVEM tri
    B Olshansky
    University of Iowa Hospitals, Iowa City, Iowa, USA
    Am J Cardiol 86:846-51. 2000
    ..Thus, over half the deaths in the ESVEM trial occurred in-hospital. The long-term actuarial risk of out-of-hospital arrhythmic death in ESVEM was unexpectedly low...
  21. ncbi request reprint Alternative medicine--boom or bust?
    Brian Olshansky
    The Section of Electrophysiology, Division of Cardiology, The University of Iowa Hospitals, Iowa City, IA 52242, USA
    Card Electrophysiol Rev 6:170-3. 2002
  22. pmc Retroactive prayer: a preposterous hypothesis?
    Brian Olshansky
    University of Iowa Hospitals, Iowa City, IA, USA
    BMJ 327:1465-8. 2003
  23. ncbi request reprint The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation
    Brian Olshansky
    University of Iowa, Iowa City, Iowa 52242, USA
    J Am Coll Cardiol 43:1201-8. 2004
    ..We sought to evaluate approaches used to control rate, the effectiveness of rate control, and switches from one drug class to another in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study...
  24. ncbi request reprint Implantable cardioverter defibrillator practices and costs at an academic medical center
    B Olshansky
    Loyola University Medical Center, Maywood, Illinois, USA
    J Cardiovasc Electrophysiol 12:162-6. 2001
    ..In the cost-to-charge ratio analysis, the mean costs for the inpatient hospitalization were $35,623. This is one of the first studies to document cost of ICD therapy and may serve as a benchmark for other facilities...
  25. ncbi request reprint The impact of atrial prevention and termination therapies on atrial tachyarrhythmia burden in patients receiving a dual-chamber defibrillator for ventricular arrhythmias
    Paul A Friedman
    Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
    J Interv Card Electrophysiol 10:103-10. 2004
    ....
  26. ncbi request reprint Apparent bidirectional conduction block following radiofrequency catheter ablation of typical atrial flutter
    R F Quintos
    Loyola University Medical Center, Maywood, Illinois, USA
    J Interv Card Electrophysiol 5:109-18. 2001
    ..The purpose of this study is to determine the reliability of activation sequence mapping in assessing the presence of bidirectional conduction block (BCB) in typical atrial flutter (AFL) ablation...
  27. ncbi request reprint Syncope in congestive heart failure
    Rakesh Gopinathannair
    Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA
    Cardiol J 15:303-12. 2008
  28. doi request reprint Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality
    T Jared Bunch
    Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
    Heart Rhythm 6:2-8. 2009
    ..Atrial fibrillation (AF) has been associated with higher rates of all-cause mortality in patients with heart failure (HF). The risk of newly detected AF in patients receiving implantable cardioverter-defibrillator (ICD) therapy is unknown...
  29. ncbi request reprint Cardioversion of atrial tachyarrhythmias: anticoagulation to reduce thromboembolic complications
    Hongsheng Guo
    University of Iowa Hospital, Iowa City, 52242, USA
    Prog Cardiovasc Dis 46:487-505. 2004
  30. ncbi request reprint Unusual response to atrial extrastimulus testing
    Stuart D Christenson
    Cardiac Electrophysiology Section, Department of Medicine, University of Iowa Hospitals and Clinics, Iowa City 52242 1081, USA
    J Cardiovasc Electrophysiol 13:200. 2002
  31. ncbi request reprint Early versus late atrial fibrillation after atrial flutter ablation
    Emmanuel Loutrianakis
    Loyola University Medical Center, 2160 S First Ave, Maywood, IL 60153, USA
    J Interv Card Electrophysiol 6:173-80. 2002
    ..Atrial fibrillation (AFib) after radiofrequency catheter ablation of AFl can occur but may be transient (lasting no more than four weeks)...
  32. doi request reprint Not so innocent bystander(s)
    Rakesh Gopinathannair
    Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, E 318 5 GH, 200 Hawkins Drive, Iowa City, IA 52242, USA
    Europace 11:1230-4. 2009
    ..This was due to antidromic AV re-entrant tachycardia with innocent bystander activation of the right atrium mimicking atrial flutter. Accessory pathway ablation effectively stopped tachycardia...
  33. doi request reprint Update on medical management of atrial fibrillation in the modern era
    Rakesh Gopinathannair
    Division of Cardiovascular Medicine, University of Iowa Hospitals, Iowa City, Iowa 52242, USA
    Heart Rhythm 6:S17-22. 2009
    ..This review updates the present state-of-the-art regarding medical management of atrial fibrillation based on present and emerging evidence...
  34. ncbi request reprint Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs
    Sally Birger Botkin
    Loyola University Chicago, Medical Center, Maywood, Ill, USA
    Am Heart J 145:233-8. 2003
    ..Outpatient direct current (DC) cardioversion is performed routinely, yet scant data support this approach. We studied the efficacy, safety, and costs of outpatient cardioversion...
  35. ncbi request reprint Reduction of right ventricular pacing in patients with dual-chamber ICDs
    Brian Olshansky
    University of Iowa Hospitals, Iowa City, Iowa 52242, USA
    Pacing Clin Electrophysiol 29:237-43. 2006
    ....
  36. ncbi request reprint Temporary biventricular pacing in a patient with subacute myocardial infarction, cardiogenic shock, and third-degree atrioventricular block
    Hongsheng Guo
    University of Iowa Hospital, 52242, USA
    Heart Rhythm 2:112. 2005
  37. ncbi request reprint Tachycardia-mediated cardiomyopathy: recognition and management
    Rakesh Gopinathannair
    University of Iowa Hospitals, 200 Hawkins Drive, 4426A JCP, Iowa City, IA 52242, USA
    Curr Heart Fail Rep 6:257-64. 2009
    ....
  38. ncbi request reprint Implantable defibrillator use for de novo ventricular tachyarrhythmias encountered after cardiac surgery
    Edward A Telfer
    University of Iowa Hospitals, Iowa City 52242, USA
    Pacing Clin Electrophysiol 25:951-6. 2002
    ..6 +/- 7.8 months and 10.5 months, respectively. De novo postoperative ventricular arrhythmias are associated with a high probability of late recurrence. The ICD is useful for these patients...
  39. doi request reprint Heart rate predicts outcomes in an implantable cardioverter-defibrillator population
    Mastaneh Ahmadi-Kashani
    Department of Medicine, University of Iowa Hospitals, 4426A JCP, 200 Hawkins Dr, Iowa City, IA 52242, USA
    Circulation 120:2040-5. 2009
    ..Our hypothesis was that mean HR predicts total mortality and heart failure hospitalization in patients undergoing implantable cardioverter-defibrillator (ICD) implantation...
  40. ncbi request reprint Irregular atrial activation during atrioventricular nodal reentrant tachycardia: evidence of an upper common pathway
    Hongsheng M Guo
    University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242, USA
    J Cardiovasc Electrophysiol 14:309-13. 2003
    ..Our observations support the concept of an upper common pathway, at least in some patients with AV nodal reentrant tachycardia...
  41. pmc Bolus isoproterenol infusions provide a reliable method for assessing interoceptive awareness
    S S Khalsa
    Neuroscience Graduate Program, Department of Neurology, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA
    Int J Psychophysiol 72:34-45. 2009
    ....
  42. ncbi request reprint Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia
    Pamela Nerheim
    University of Iowa Hospitals, Iowa City, IA 52242 1081, USA
    Circulation 110:247-52. 2004
    ....
  43. ncbi request reprint Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study
    Jonathan S Steinberg
    Division of Cardiology, St Luke s Roosevelt Hospital Center and Columbia University, New York, NY 10025, USA
    Circulation 109:1973-80. 2004
    ..This report describes the cause-specific modes of death in the AFFIRM treatment groups...
  44. ncbi request reprint Ventricular tachycardia with QRS configuration similar to that in sinus rhythm and a myocardial origin: differential diagnosis with bundle branch reentry
    H Guo
    Department of Medicine, Loyola University Medical Center, Maywood, Illinois, USA
    Europace 3:115-23. 2001
    ..Although it mimics usual bundle branch reentry, this form of ventricular tachycardia appears to be due to a different mechanism in which the His bundle is not obligatory for the continuation of the reentrant phenomenon...
  45. doi request reprint Antiarrhythmic effects of statins in heart failure
    Chirag M Sandesara
    University of Iowa Hospitals and Clinics, Iowa City, IA, USA
    Heart Fail Clin 4:187-200. 2008
    ..Ongoing and future clinical trials will likely resolve the discrepancies between studies and further the understanding of how pleiotropic properties of statins can be antiarrhythmic in patients who have heart failure...
  46. ncbi request reprint Hope for a better world
    Brian Olshansky
    Division of Cardiology, Department of Internal Medicine, University of Iowa Health Care, Iowa City, IA 52242, USA
    Cardiol Rev 11:306-8. 2003
  47. ncbi request reprint Pericarditis in myasthenia gravis
    Hemender S Vats
    Department of Internal Medicine, University of Iowa Hospitals and Clinics Iowa City, Iowa, USA
    Cardiol Rev 12:134-7. 2004
    ..We report the presence of pericardial effusion and atrioventricular conduction block in a patient with myasthenia gravis that responded appropriately to immunosuppressive therapy and plasma exchanges...
  48. ncbi request reprint Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II
    Anant K Vyas
    Heart Research Follow up Program of the Cardiology Unit of the Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA
    J Am Coll Cardiol 47:769-73. 2006
    ....
  49. ncbi request reprint Combining ablation of atrial fibrillation with ablation of atrial flutter: are we there yet?
    Brian Olshansky
    J Am Coll Cardiol 43:2063-5. 2004
  50. ncbi request reprint Electrophysiological characterization of cardiac veins in humans
    David A Cesario
    UCLA Cardiac Arrhythmia Center, David Geffen School of Medicine at UCLA, Los Angeles CA
    J Interv Card Electrophysiol 10:241-7. 2004
    ..The purpose of this study was to evaluate the electrical activity of the coronary sinus (CS), great cardiac vein (GCV) and related structures, such as the Vein of Marshall (VOM)...
  51. ncbi request reprint Advances in atrial flutter mapping: what goes around comes around
    Brian Olshansky
    J Cardiovasc Electrophysiol 15:415-7. 2004
  52. ncbi request reprint Addendum to the clinical competency statement: training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices
    John D Day
    Utah Cardiovascular Research Institute, Utah Heart Clinic, LDS Hospital, Salt Lake City, Utah, USA
    Heart Rhythm 2:1161-3. 2005
  53. doi request reprint High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems
    John D Day
    Utah Heart Clinic Arrhythmia Services, LDS Hospital, 324 10th Avenue, Suite 206, Salt Lake City, UT 84103, USA
    Europace 10:347-50. 2008
    ..Little data are available on the number of patients who do not have a 10 J margin initially and therefore require system revisions, further testing, or a higher energy output device...
  54. ncbi request reprint Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and In
    John H K Vogel
    J Am Coll Cardiol 46:184-221. 2005
  55. ncbi request reprint A practical guide for clinicians who treat patients with amiodarone: 2007
    Nora Goldschlager
    University of California, San Francisco, California, USA
    Heart Rhythm 4:1250-9. 2007
    ..The recommendations included herein are based on the best available data and the collective experience of the member of the writing committee...
  56. ncbi request reprint Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry
    Matthew R Reynolds
    Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Am J Cardiol 97:538-43. 2006
    ..The discontinuation of warfarin in a large number of patients with AF over time is a cause for concern in light of data from recent clinical trials...
  57. ncbi request reprint Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies
    Isabelle C Van Gelder
    Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, PO Box 30 001, 9700 RB Groningen, The Netherlands
    Europace 8:935-42. 2006
    ..The AFFIRM and RACE studies showed that rate control is an acceptable treatment strategy for atrial fibrillation (AF). We examined whether strict rate control offers benefit over more lenient rate control...
  58. ncbi request reprint Is the approach to atrial fibrillation ablation becoming more complex and fractionated?
    Brian Olshansky
    Heart Rhythm 3:35-6. 2006
  59. ncbi request reprint Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Michael G Dickinson
    Thoracic Cardiovascular Institute Foundation, Lansing, MI, USA
    Am Heart J 153:573-8. 2007
    ..The study length, size, and degree of background HF, including the use of implantable defibrillator therapy, provide a unique opportunity to evaluate the impact of statin use in HF with mechanistic insights from subgroup analyses...
  60. ncbi request reprint Wide QRS, narrow QRS: what's the difference?
    Brian Olshansky
    J Am Coll Cardiol 46:317-9. 2005
  61. pmc Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation
    Vidal Essebag
    Division of Cardiology, McGill University Health Center, Montreal, Quebec, Canada
    Arch Intern Med 167:1648-53. 2007
    ..The aims of this study were to determine prospectively whether amiodarone increases the need for pacemakers in a general population of patients with AF and whether this effect is modified by sex...
  62. ncbi request reprint Task Force 9: drugs and performance-enhancing substances
    N A Mark Estes
    J Am Coll Cardiol 45:1368-9. 2005
  63. ncbi request reprint High intensity anticoagulation for cardioversion of atrial arrhythmias? The shocking truth
    Brian Olshansky
    J Am Coll Cardiol 40:934-6. 2002
  64. ncbi request reprint Etiologic considerations in the patient with syncope and an apparently normal heart
    Nora Goldschlager
    Cardiology Division, 1001 Potrero Ave, Room 5G1, San Francisco General Hospital, San Francisco, CA 94110, USA
    Arch Intern Med 163:151-62. 2003
  65. ncbi request reprint Complementary and alternative medicine: the need for data
    Brian Olshansky
    Cardiol Rev 11:53-5. 2003
  66. ncbi request reprint Inadvertent positioning of pacemaker leads in the pericardium
    Kambeez Berenji
    Department of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Pacing Clin Electrophysiol 26:2039-41. 2003
    ..The lead position on chest X ray and the ECG pattern indicated lead malposition, but a CT scan and transesophageal echocardiography were nondiagnostic. Venography indicated that both leads were in the mediastinal and pericardial space...
  67. ncbi request reprint Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of heart rhythm society members
    Rachel Lampert
    Yale University School of Medicine, Department of Medicine, New Haven, Connecticut 06520, USA
    J Cardiovasc Electrophysiol 17:11-5. 2006
    ..Safety of Sports for ICD Patients...
  68. ncbi request reprint Variation in the utilization of antiarrhythmic drugs in patients with new-onset atrial fibrillation
    Peter Zimetbaum
    Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Clinical Research Institute, Boston, Massachusetts 02215, USA
    Am J Cardiol 91:81-3. 2003
  69. ncbi request reprint The ACCF/AHA scientific statement on syncope needs rethinking
    David G Benditt
    J Am Coll Cardiol 48:2598-9; author reply 2599. 2006
  70. ncbi request reprint The "pill-in-the-pocket" approach to atrial fibrillation
    Suma H Konety
    N Engl J Med 352:1150-1; author reply 1150-1. 2005
  71. ncbi request reprint Arrhythmias in tako-tsubo syndrome--benign or malignant?
    Suma H Konety
    Int J Cardiol 114:141-4. 2007
    ..We present a unique case of tako-tsubo syndrome in a 71-year-old woman who developed symptomatic ventricular arrhythmias after complete resolution of cardiomyopathy...
  72. ncbi request reprint Treating patients with overactive bladder syndrome with antimuscarinics: heart rate considerations
    Karl Erik Andersson
    Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USA
    BJU Int 100:1007-14. 2007
    ..This is without doubt the most detailed and the most reader-friendly paper on this subject, and I am sure that it will help urologists to assist in further educating their patients when prescribing these compounds...